v3.25.2
Commitments and Contingencies - Additional Information (Details) - USD ($)
 12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2013
May 06, 2024
Loss Contingencies [Line Items]        
Lessee, operating lease, option to extend On September 27, 2022, the Company entered into the First Amendment to Lease (the “Lease Amendment”), which amended the Lease Agreement to document the exercise of its option to extend the term of the lease for an additional 64 months, commencing February 1, 2023, and expiring on May 31, 2028 (the “Extension Term”). Pursuant to the amendment, the Company will pay initial monthly payments of $13,129, beginning February 2023, subject to 3% annual increases.      
Operating lease percentage of annual increase 3.00%      
Operating lease commencing date Feb. 01, 2023      
Operating lease expiring date May 31, 2028      
Operating lease option to extend additional lease term 64 months      
Initial monthly payments $ 13,129      
Rent expense $ 203,459 $ 187,517    
Operating lease incremental borrowing rate 12.00%      
Common stock, par value $ 0.001 $ 0.001   $ 0.001
Royalty Agreements        
Loss Contingencies [Line Items]        
Royalty not paid balance amount     $ 3,500,000  
Royalties total amount     $ 3,500,000  
Common stock, par value     $ 6,875  
Receipt of bona fide offer valuing common stock     $ 6,875  
Aggregate payment of royalties     3,000,000  
Royalty Agreements | Loan and Security Agreement        
Loss Contingencies [Line Items]        
Notes payable     1,000,000  
Royalty Agreements | MyoVista Devices        
Loss Contingencies [Line Items]        
Royalty payment upon paid for each device amount     200  
Royalty Agreements | 2,400 MyoVista Devices        
Loss Contingencies [Line Items]        
Royalty payment upon paid for each device amount     $ 500